Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel proteasome inhibitor CEP-18770 in human plasma and its application in a clinical pharmacokinetic study
2019 ◽
Vol 1117
◽
pp. 77-85
◽
2006 ◽
Vol 20
(19)
◽
pp. 2845-2850
◽
2019 ◽
Vol 1603
◽
pp. 165-178
◽
2009 ◽
Vol 50
(5)
◽
pp. 959-965
◽
2014 ◽
Vol 962
◽
pp. 20-29
◽